These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. In Vitro Synergistic Activity of Rifampicin Combined with Minimal Effective Antibiotic Concentration (MEAC) of Polymyxin B Against Extensively Drug-Resistant, Carbapenem-, and Polymyxin B-Resistant Klebsiella pneumoniae Clinical Isolates. Abichabki N; Gaspar GG; Zacharias LV; Pocente RHC; Lima DAFS; de Freitas NAB; Brancini GTP; Moreira NC; Braga GÚL; Bellissimo-Rodrigues F; Bollela VR; Darini ALC; Andrade LN Curr Microbiol; 2024 Sep; 81(11):371. PubMed ID: 39307852 [TBL] [Abstract][Full Text] [Related]
3. From Breast Cancer to Antimicrobial: Combating Extremely Resistant Gram-Negative "Superbugs" Using Novel Combinations of Polymyxin B with Selective Estrogen Receptor Modulators. Hussein MH; Schneider EK; Elliott AG; Han M; Reyes-Ortega F; Morris F; Blastovich MAT; Jasim R; Currie B; Mayo M; Baker M; Cooper MA; Li J; Velkov T Microb Drug Resist; 2017 Jul; 23(5):640-650. PubMed ID: 27935770 [TBL] [Abstract][Full Text] [Related]
4. Polymyxin combination therapy for multidrug-resistant, extensively-drug resistant, and difficult-to-treat drug-resistant gram-negative infections: is it superior to polymyxin monotherapy? Ardebili A; Izanloo A; Rastegar M Expert Rev Anti Infect Ther; 2023 Apr; 21(4):387-429. PubMed ID: 36820511 [TBL] [Abstract][Full Text] [Related]
5. In vitro activity of doripenem alone and in multi-agent combinations against extensively drug-resistant Acinetobacter baumannii and Klebsiella pneumoniae. Clock SA; Tabibi S; Alba L; Kubin CJ; Whittier S; Saiman L Diagn Microbiol Infect Dis; 2013 Jul; 76(3):343-6. PubMed ID: 23601454 [TBL] [Abstract][Full Text] [Related]
6. Comparison of antibacterial activities of polymyxin B and colistin against multidrug resistant Gram negative bacteria. Doymaz MZ; Karaaslan E Infect Dis (Lond); 2019 Sep; 51(9):676-682. PubMed ID: 31298061 [No Abstract] [Full Text] [Related]
7. Chen H; Li H; Liu Z; Li J Microb Drug Resist; 2020 Sep; 26(9):1108-1119. PubMed ID: 32349617 [TBL] [Abstract][Full Text] [Related]
8. Potent synergy and sustained bactericidal activity of polymyxins combined with Gram-positive only class of antibiotics versus four Gram-negative bacteria. Wang Y; Feng J; Yu J; Wen L; Chen L; An H; Xiao W; Zhang B; Feng H; Zhou M; Jiang Z Ann Clin Microbiol Antimicrob; 2024 Jul; 23(1):60. PubMed ID: 38965559 [TBL] [Abstract][Full Text] [Related]
9. Combining Colistin with Furanone C-30 Rescues Colistin Resistance of Gram-Negative Bacteria Zhang Y; Lin Y; Zhang X; Chen L; Xu C; Liu S; Cao J; Zheng X; Jia H; Chen L; Zhou T Microbiol Spectr; 2021 Dec; 9(3):e0123121. PubMed ID: 34730415 [TBL] [Abstract][Full Text] [Related]
10. Polymyxin combined with de Melo ALF; Rossato L; Velasques J; de Sousa VL; Pina Rodrigues GV; Cardoso CAL; Arantes JP; Lima BF; Simionatto S J Med Microbiol; 2024 Sep; 73(9):. PubMed ID: 39292222 [No Abstract] [Full Text] [Related]
11. Repurposing Non-Antibiotic Drugs Auranofin and Pentamidine in Combination to Combat Multidrug-Resistant Gram-Negative Bacteria. Yu Y; Zhao H; Lin J; Li Z; Tian G; Yang YY; Yuan P; Ding X Int J Antimicrob Agents; 2022 May; 59(5):106582. PubMed ID: 35378227 [TBL] [Abstract][Full Text] [Related]
12. Synergistic effect between nisin and polymyxin B against pandrug-resistant and extensively drug-resistant Acinetobacter baumannii. Thomas VM; Brown RM; Ashcraft DS; Pankey GA Int J Antimicrob Agents; 2019 May; 53(5):663-668. PubMed ID: 30880230 [TBL] [Abstract][Full Text] [Related]
13. Unveiling synergism of polymyxin B with chloramphenicol derivatives against multidrug-resistant (MDR) Klebsiella pneumoniae. Idris N; Leong KH; Wong EH; Abdul Rahim N J Antibiot (Tokyo); 2023 Dec; 76(12):711-719. PubMed ID: 37821539 [TBL] [Abstract][Full Text] [Related]
14. Novel Polymyxin Combination with the Antiretroviral Zidovudine Exerts Synergistic Killing against NDM-Producing Multidrug-Resistant Klebsiella pneumoniae. Lin YW; Abdul Rahim N; Zhao J; Han ML; Yu HH; Wickremasinghe H; Chen K; Wang J; Paterson DL; Zhu Y; Rao GG; Zhou QT; Forrest A; Velkov T; Li J Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30670431 [TBL] [Abstract][Full Text] [Related]
15. Activity of polymyxin B and the novel polymyxin analogue CB-182,804 against contemporary Gram-negative pathogens in New York City. Quale J; Shah N; Kelly P; Babu E; Backer M; Rosas-Garcia G; Salamera J; George A; Bratu S; Landman D Microb Drug Resist; 2012 Apr; 18(2):132-6. PubMed ID: 22196342 [TBL] [Abstract][Full Text] [Related]
16. Biogenic silver nanoparticle (Bio-AgNP) has an antibacterial effect against carbapenem-resistant Acinetobacter baumannii with synergism and additivity when combined with polymyxin B. Allend SO; Garcia MO; da Cunha KF; de Albernaz DTF; da Silva ME; Ishikame RY; Panagio LA; Nakazaro G; Reis GF; Pereira DB; Hartwig DD J Appl Microbiol; 2022 Feb; 132(2):1036-1047. PubMed ID: 34496109 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of the in vitro synergy of polymyxin B-based combinations against polymyxin B -resistant gram-negative bacilli. Li Y; Guo S; Li X; Yu Y; Yan B; Tian M; Xu B; Hu H Microb Pathog; 2022 May; 166():105517. PubMed ID: 35398467 [TBL] [Abstract][Full Text] [Related]
18. Synergism of eravacycline combined with other antimicrobial agents against carbapenem-resistant Enterobacteriaceae and Acinetobacter baumannii. Li Y; Cui L; Xue F; Wang Q; Zheng B J Glob Antimicrob Resist; 2022 Sep; 30():56-59. PubMed ID: 35660472 [TBL] [Abstract][Full Text] [Related]
19. Resveratrol enhances the antimicrobial effect of polymyxin B on Klebsiella pneumoniae and Escherichia coli isolates with polymyxin B resistance. Liu L; Yu J; Shen X; Cao X; Zhan Q; Guo Y; Yu F BMC Microbiol; 2020 Oct; 20(1):306. PubMed ID: 33045992 [TBL] [Abstract][Full Text] [Related]
20. The Antibacterial Activity of Kaempferol Combined with Colistin against Colistin-Resistant Gram-Negative Bacteria. Zhou H; Xu M; Guo W; Yao Z; Du X; Chen L; Sun Y; Shi S; Cao J; Zhou T Microbiol Spectr; 2022 Dec; 10(6):e0226522. PubMed ID: 36314964 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]